Yea, this definitely sounds like someone with expe
Post# of 148175
(Total Views: 706)
Posted On: 07/17/2020 1:38:44 AM
Re: reallypeople? #43383
Yea, this definitely sounds like someone with experience in CMC space.
It was made clear very early on by Cytodyn, through the PR, that this isn’t a major issue. The market reacted disproportionally simply because...they don’t know what their doing (inexperienced investors or with lack of understanding) and/or they’re bullying us (shorts etc).
Bringing a drug to the market is a journey, the path of which isn’t paved with roses, especially for the novices. I have faith in the drug and I believe results will be very good. There’s a real possibility that we see important gains by the end of next week, no doubt. I’m less optimistic when it comes to the other indications. The medical need is less unmet than for Covid, the company is not experienced with bringing drugs to the market, so timelines will be prolonged IMO. On the other hand though, if Covid news are good, the momentum of the company could result in better collaborations and more favoritism.
Buckle up people. Good or bad, this is gonna be quite the trip.
It was made clear very early on by Cytodyn, through the PR, that this isn’t a major issue. The market reacted disproportionally simply because...they don’t know what their doing (inexperienced investors or with lack of understanding) and/or they’re bullying us (shorts etc).
Bringing a drug to the market is a journey, the path of which isn’t paved with roses, especially for the novices. I have faith in the drug and I believe results will be very good. There’s a real possibility that we see important gains by the end of next week, no doubt. I’m less optimistic when it comes to the other indications. The medical need is less unmet than for Covid, the company is not experienced with bringing drugs to the market, so timelines will be prolonged IMO. On the other hand though, if Covid news are good, the momentum of the company could result in better collaborations and more favoritism.
Buckle up people. Good or bad, this is gonna be quite the trip.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼